The city of Kansas City, Kansas, currently has 4 active clinical trials seeking participants for Alzheimer's Disease research studies.
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Recruiting
The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 250 participants in total including co-enrolled in the Alzheimer Biomarkers Consortium - Down Syndrome (ABC-DS) study. Participants enrolled in the TRC-DS will undergo longitudinal cognitive and clinical assessment, genetic and biomarker testing, as well as imaging and biospecimen collection. Using these outc... Read More
Gender:
All
Ages:
Between 25 years and 55 years
Trial Updated:
03/06/2024
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Down Syndrome, Alzheimer Disease, Dementia
Whole Egg Intake and Choline Concentration in the Aging Brain
Recruiting
By doing this study, researchers hope to learn to see if there is relationship between whole egg consumption and brain choline status. Additionally, researchers also plan to see if there is a relationship between brain choline status and cognition.
Gender:
All
Ages:
Between 60 years and 85 years
Trial Updated:
05/24/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Alzheimer Disease
Changing Talk Online Training (CHATO) National Trial
Recruiting
The National Plan to Address Alzheimer's disease has identified education of dementia care providers as a top priority to address the need for quality care for the population of persons with dementia that will triple in the next 30 years. This study will test new online interactive training for nursing home staff that improves staff communication and also reduces behavioral symptoms of persons with dementia that they care for. Innovative approaches to reach care providers are essential to achiev... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2023
Locations: University of Kansas School of Nursing, Kansas City, Kansas
Conditions: Dementia, Alzheimer Disease, Communication
Creatine to Augment Bioenergetics in Alzheimer's
Recruiting
By doing this study, researchers hope to see if creatine monohydrate is a helpful treatment for people with Alzheimer's disease.
Gender:
All
Ages:
Between 60 years and 90 years
Trial Updated:
01/09/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Alzheimer's Disease